Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), and Aragen Bioscience, a contract research organization (CRO) focused on accelerating pre-clinical biologics product development, have entered a co-marketing agreement that will provide clients an integrated “sequence-to-manufacturing” service. Under terms of the non-exclusive agreement, the companies will offer customers Aragen’s cell line development expertise integrated with Avid’s upstream and downstrea...